Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on September 23, 2026, Federal Biotech has received US$9 million from Novo Pay for the global phase I clinical milestone payment for UBT251 injection for type 2 diabetes indications (after deducting Danish withholding tax).

Zhitongcaijing · 2d ago
Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on September 23, 2026, Federal Biotech has received US$9 million from Novo Pay for the global phase I clinical milestone payment for UBT251 injection for type 2 diabetes indications (after deducting Danish withholding tax).